Friday, June 20, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2021

Yearly Archives: 2021

Hapbee
Telehealth

2021 Breakthrough Wearable Tech: Overview on Hapbee (HAPB, HAPBF) and its...

Editor / Curator -
Hapbee
Telehealth

Interview: Scott Donnell from Hapbee (HAPB, HAPBF) on Wall Street Reporter.

Editor / Curator -
2020 Watch List

Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to...

Editor / Curator -
Emulate Therapeutics
All News

EMulate Therapeutics to Participate in the Venture Summit – Virtual Connect...

Editor / Curator -
All News

Wall Street Pounces on Hydroponics.

Editor / Curator -
Internet News

Another Look at the Snowflake (SNOW) Mega IPO.

Editor / Curator -
Citius
Biotech News

Wall Street Showing Love. Hepion Pharma (HEPA), Citius Pharma (CTXR) Raise...

Editor / Curator -
Stem Cells

Video: Mel Gibson Stem Cell Testimonial.

Editor / Curator -
CB Scientific
Telehealth

Philips (PHG) Completes the Acquisition of BioTelemetry, Inc.

Editor / Curator -
Precious Metals

Silver Alert. “Press the Pedal to the Metal.”

Editor / Curator -
1...16171819Page 17 of 19

Latest article

Jeffrey Gundlach: Reckoning is Coming.

All News Editor / Curator -
Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

All News Editor / Curator -
Eric Sprott, on Who is the Next Eric Sprott! To say Eric Sprott has left a legendary mark on the world of mining investment would...

Perpetua (PPTA) Raises $300 Million.

All News Editor / Curator -
Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.